Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - MOBIX LABS, INC (0001855467) (Filer)
Automated noteMobix Labs, Inc. filed a Form 8-K reporting a material definitive agreement, a new direct financial obligation, unregistered equity sales, changes to security holder rights, director/officer departures and appointments with related compensation, and accompanying financial statements.
- 8-K - PILGRIMS PRIDE CORP (0000802481) (Filer)
Automated notePilgrims Pride Corp filed a Form 8-K on August 28, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Constellation Acquisition Corp I (0001834032) (Filer)
Automated noteConstellation Acquisition Corp I filed a Form 8-K on August 28, 2026, disclosing the creation of a direct financial obligation and/or an off-balance-sheet arrangement as required under Item 2.03.
- 8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)
Automated noteIntelligent Bio Solutions Inc. filed a Form 8-K on August 28, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.
- 8-K - POWERCOMPUTE, INC. (0001640384) (Filer)
Automated notePowerCompute, Inc. filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.
- 8-K - Glucotrack, Inc. (0001506983) (Filer)
Automated noteGlucotrack, Inc. filed a Form 8-K on August 28, 2026, reporting amendments to its articles of incorporation or bylaws, a change in fiscal year, other events, and accompanying financial statements and exhibits.
- 8-K - ALLIANCE ENTERTAINMENT HOLDING CORP (0001823584) (Filer)
Automated noteAlliance Entertainment Holding Corp filed a Form 8-K reporting amendments to its articles of incorporation and bylaws, a change in fiscal year, and accompanying financial statements and exhibits.
- 8-K - RenX Enterprises Corp. (0001959023) (Filer)
Automated noteRenX Enterprises Corp filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - T1 Energy Inc. (0001992243) (Filer)
Automated noteT1 Energy Inc. filed an 8-K with the SEC on August 28, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The filing is accessible under accession number 0001213900-26-095184.
- 8-K - Coherus Oncology, Inc. (0001512762) (Filer)
Automated noteCoherus Oncology, Inc. filed a Form 8-K with the SEC on August 28, 2026 (Accession No. 0001104659-26-103316), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - AIRWA INC. (0001674440) (Filer)
Automated noteAirwa Inc. filed a Form 8-K on August 28, 2026, disclosing a notice of delisting or failure to satisfy a continued listing rule, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - LEHMAN ABS CORP GOLDMAN SACHS CAP 1 SEC BACKED SER 2004-6 (0001284143) (Filer)
Automated noteLehman ABS Corp filed a Form 8-K on August 28, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer)
Automated noteCumberland Pharmaceuticals Inc. filed a Form 8-K on August 28, 2026, providing a Regulation FD Disclosure under Item 7.01.
- 8-K - ORAGENICS INC (0001174940) (Filer)
Automated noteOragenics Inc. filed a Form 8-K reporting a notice of delisting and a transfer of its listing, along with other events and accompanying financial statements and exhibits.
- 8-K - TPG Twin Brook Capital Income Fund (0001913724) (Filer)
Automated noteTPG Twin Brook Capital Income Fund filed a Form 8-K on August 28, 2026, reporting a Regulation FD Disclosure and other events, as disclosed in accession number 0001913724-26-000026.
- 8-K - Sezzle Inc. (0001662991) (Filer)
Automated noteSezzle Inc. submitted a Form 8-K filing under Item 8.01 (Other Events) on August 28, 2026, with accession number 0001662991-26-000148.
- 8-K - SOCKET MOBILE, INC. (0000944075) (Filer)
Automated noteSocket Mobile, Inc. filed a Form 8-K indicating it received a notice of delisting or failure to satisfy a continued listing rule and that its securities will be transferred to a different listing.
- 8-K - SRX Global Inc. (0001471727) (Filer)
Automated noteSRX Global Inc. filed a Form 8-K on August 28, 2026 reporting entry into a material definitive agreement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - PEDEVCO CORP (0001141197) (Filer)
Automated notePeDevCo Corp filed a Form 8-K reporting the departure and appointment of certain directors and officers, related compensation arrangements, items submitted for shareholder vote, and accompanying financial statements and exhibits.
- 8-K - Sinclair, Inc. (0001971213) (Filer)
Automated noteSinclair, Inc. filed an 8-K on August 28, 2026 reporting the departure and appointment of certain directors and officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - Crinetics Pharmaceuticals, Inc. (0001658247) (Filer)
Automated noteCrinetics Pharmaceuticals filed a Form 8-K on August 28, 2026, reporting a submission of matters to a vote of security holders (Item 5.07) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - NORWOOD FINANCIAL CORP (0001013272) (Filer)
Automated noteNorwood Financial Corp filed a Form 8-K on August 28, 2026, reporting other events under Item 8.01 and including financial statements and related exhibits under Item 9.01.
- 8-K - BiomX Inc. (0001739174) (Filer)
Automated noteBiomX Inc. filed a Form 8-K on August 28, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001213900-26-095146.
- 8-K - IonQ, Inc. (0001824920) (Filer)
Automated noteIonQ, Inc. filed a Form 8-K reporting departures and appointments of directors and certain officers, related compensatory arrangements, other events, and included its financial statements and accompanying exhibits.
- 8-K - Andretti Acquisition Corp. II (0002025341) (Filer)
Automated noteAndretti Acquisition Corp. II filed a Form 8-K reporting entry into a material definitive agreement, submission of matters to a shareholder vote, other events, and accompanying financial statements and exhibits.
- 8-K - SharonAI Holdings Inc. (0002068385) (Filer)
Automated noteSharonAI Holdings Inc. filed a Form 8-K reporting the departure, election or appointment of directors and certain officers, related compensatory arrangements, matters submitted for a shareholder vote, and accompanying financial statements and exhibits.
- 8-K - Simulations Plus, Inc. (0001023459) (Filer)
Automated noteSimulations Plus, Inc. filed an 8-K on August 28, 2026, containing Item 5.07 regarding matters submitted for a security-holder vote and Item 9.01 providing financial statements and related exhibits.
- 8-K - Cyber App Solutions Corp. (0001851048) (Filer)
Automated noteCyber App Solutions Corp. filed a Form 8-K with the SEC on August 28, 2026, reporting under Item 8.01 (Other Events) (Accession No. 0001851048-26-000017).
- 8-K - Katapult Holdings, Inc. (0001785424) (Filer)
Automated noteKatapult Holdings, Inc. filed a Form 8-K on August 28, 2026, disclosing entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - Real REMAX Group Inc. (0002136387) (Filer)
Automated noteReal RE/MAX Group Inc. filed a Form 8-K on August 28, 2026, disclosing the departure, election or appointment of certain directors and officers and related compensatory arrangements pursuant to Item 5.02.